Effect of a Dihydroxyacetone‐Based Camouflage Agent on Ultraviolet‐Induced Erythema
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70587 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Dan Shu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, P.R. China. Hauptthemen laut MEDLINE: Erythema, Ultraviolet Rays, Dihydroxyacetone, Ultraviolet Therapy. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Hospitals Authority's Ascent Plan, National Key Research and Development Program of China.
Abstract (Originalsprache)
Background
Vitiligo is an acquired, idiopathic skin disease of dyspigmentation, affecting approximately 0.5%–2% of the global population. However, it is not clear whether dihydroxyacetone (DHA)‐based camouflage could affect the effectiveness of ultraviolet (UV) therapy. Therefore, we aimed to investigate the effect of a camouflage agent containing 3.6% DHA on UV‐induced erythema.
Methods
Fifty‐one healthy volunteers of skin type III to IV who came to the hospital were recruited in this study. A 308 nm excimer UV lamp was used to perform the minimum erythema dose (MED) test on the lower back and a camouflage agent containing 3.6% DHA was applied. Four groups were tested on the same individuals (subjects served as their own controls), including no camouflage nor irradiation (Group A), irradiation without camouflage (Group B), camouflage without irradiation (Group C), and camouflage plus irradiation (Group D). Refined MED was evaluated via naked eyes (erMED) and digital dermatoscopes (drMED), The erythema index (EI) value of the targeted site was measured by dermatoscopic digital imaging and analyzed.
Results
After the camouflage masking, 43 (84.3%) subjects remained unchanged in erMED, 7 (13.7%) had a MED increase of one grade (+10 mJ/cm 2 ), and only one (2.0%) had a MED increase of two grades (+20 mJ/cm 2 ). Although statistically significant differences were observed in MED ( p = 0.0047) and EI values ( p = 0.0015) between groups with and without camouflage, these differences were clinically minimal. No significant difference was observed between erMED and drMED in Group B ( p = 0.157) or D ( p = 0.317).
Conclusion
The camouflage agent containing 3.6% DHA exhibits statistically significant but clinically negligible effects on erythema in volunteers exposed to 308 nm UV light, requiring no dose adjustment in 84.3% of cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, P.R. China.
- School of Clinical Medicine, Tsinghua University, Beijing, China.
ORCID-Profile: Yi Zhao
Förderung
- Beijing Hospitals Authority's Ascent Plan
- National Key Research and Development Program of China
Zitieren
APA
Shu, D., Han, Y., Chen, D., Li, Z., & Zhao, Y. (2025). Effect of a Dihydroxyacetone‐Based Camouflage Agent on Ultraviolet‐Induced Erythema. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70587
Vancouver
Shu D, Han Y, Chen D, Li Z, Zhao Y. Effect of a Dihydroxyacetone‐Based Camouflage Agent on Ultraviolet‐Induced Erythema. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70587
BibTeX
@article{Shu2025,
author = {Shu, Dan and Han, Yiting and Chen, Dian and Li, Zhenghui and Zhao, Yi},
title = {Effect of a Dihydroxyacetone‐Based Camouflage Agent on Ultraviolet‐Induced Erythema},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70587}
}
EUVIMED